Published in Drug Week, March 9th, 2007
Hinson, 41, a resident of Washington, D.C., is vice president of clinical and regulatory affairs for Symphony Medical, Inc., a privately held developer of proprietary biopolymer and cellular-based biologic therapies to treat arrhythmias, structural heart disease, and other cardiac abnormalities. Prior to joining Symphony Medical in November 2004, he was senior director of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.